The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

James Ratcliff joined GameRant in 2022 as a Gaming News Writer. In 2023, James was offered a chance to become an occasional feature writer for different games and then a Senior Author in 2025. He is a ...

ASM's Annual Report 2025 is available in ESEF reporting package and as a PDF file on the company's website www.asm.com. ASM publishes the Annual Report in accordance with European Single Electronic ...

Shares in ASM International rose on Wednesday after the Dutch supplier of semiconductor tools posted a better-than-expected finish to the year and set strong guidance for 2026 on the back of improved ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform ...

If you're craving your favorite drive-through but it is not the day to go and get it, you can easily make these copycat fast food recipes at home with healthier (and more affordable!) ingredients.

The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss ...

Did you hear the one about the project doing an expansion before it’s even completed? That, in a nutshell, is the story of ASM at the Scottsdale Development Review Board Dec. 11 meeting. According to ...

In Pennsylvania, too many families know the devastating toll obesity and related chronic diseases can take. Access to safe, effective medications can change lives, and when you need medication, you ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs. By Rebecca Robbins The Food and Drug Administration ...